Atlas Trials

Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

Clinical trial NCT00765245 · COMPLETED

Trial details

NCT number
NCT00765245
Sponsor
Vanderbilt-Ingram Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2008-10-01
Primary completion
2014-11-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.